Prothrombin Segovia: a new congenital abnormality of prothrombin.

A family with a new congenital dysprothrombinemia is presented. The propositus is a 21-yr-old man who presented simultaneously with hemartrosis of the left knee and an extensive hematoma following a minor trauma. Prothrombin time and activated partial thromboplastin time were prolonged. Prothrombin activity was very low when measured by biological assay using physiological activators (7% by one-stage method and 20% by two-stage method) or a Russel's viper venom-cephalin mixture (23%), Notechis scutatus scutatus venom (15%) and Echis carinatus venom (17%); in contrast, the level was found to be borderline to normal using Taipan viper venom (64%) and normal by both staphylocoagulase and immunologic methods. Family studies revealed consanguinity between the propositus' mother and father and both presented a 50% reduced prothrombin level when physiological activators or Echis carinatus viper venom were used. A line of identity between normal and abnormal prothrombin was observed on immunodiffusion. The migration of the abnormal prothrombin was less anodic and was not changed by the addition of calcium. The patient's serum showed 3 bands in the bidimensional immunoelectrophoresis system, whereas normal serum showed only 2 bands. The term prothrombin Segovia is proposed to define this new prothrombin abnormality.

[1]  C. Soria,et al.  Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin. , 1984, Thrombosis research.

[2]  M. Jandrot-Perrus,et al.  Thrombin Metz: characterization of the dysfunctional thrombin derived from a variant of human prothrombin. , 1984, Blood.

[3]  A. Bezeaud,et al.  CHARACTERIZATION OF A VARIANT OF HUMAN PROTHROMBIN: PROTHROMBIN MADRID , 1981, Annals of the New York Academy of Sciences.

[4]  K. Mann,et al.  Identification of a congenital dysthrombin, thrombin Quick. , 1980, The Journal of clinical investigation.

[5]  D. Labie,et al.  Purification and partial characterization of a new variant of human prothrombin: prothrombin Metz , 1979, FEBS letters.

[6]  D. Labie,et al.  Activation of prothrombin Barcelona. Evidence for active high molecular weight intermediates. , 1979, Biochimica et biophysica acta.

[7]  G. Palareti,et al.  Prothrombin Molise: a "new" congenital dysprothrombinemia, double heterozygosis with an abnormal prothrombin and "true" prothrombin deficiency. , 1978, Blood.

[8]  T. Suzuki,et al.  The mechanism of activation of bovine prothrombin by an activator isolated from Echis carinatus venon and characterization of the new active intermediates. , 1976, Journal of biochemistry.

[9]  C. Esmon,et al.  The functional significance of vitamin K action. Difference in phospholipid binding between normal and abnormal prothrombin. , 1975, The Journal of biological chemistry.

[10]  C M Jackson,et al.  The conversion of prothrombin to thrombin. IV. The function of the fragment 2 region during activation in the presence of factor V. , 1974, The Journal of biological chemistry.

[11]  W. Owen,et al.  Activation of prothrombin with oxyuranus scutellatus scutellatus (taipan snake) venom , 1973 .

[12]  R. Biggs,et al.  The Specific Assay of Prothrombin Using the Taipan Snake Venom , 1971, British journal of haematology.

[13]  S. Shapiro,et al.  Congenital dysprothrombinemia: an inherited structural disorder of human prothrombin. , 1969, The Journal of clinical investigation.

[14]  H. G. Clarke,et al.  Quantitative immunoelectrophoresis of human serum proteins. , 1968, Clinical science.

[15]  M. Esnouf,et al.  Coagulant Activity of Tiger Snake (Notechis scutatus scutatus) Venom , 1966, Nature.

[16]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[17]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[18]  P. Owren,et al.  A simple, specific one-stage prothrombin assay using Russell's viper venom in cephalin suspension. , 1955, The Journal of laboratory and clinical medicine.

[19]  A. S. Douglas,et al.  The Measurement of Prothrombin in Plasma , 1953, Journal of clinical pathology.

[20]  H. Bohn,et al.  Eine quantitative Bestimmung von Faktor XIII mit Anti-Faktor-XIII-Serum , 1968, Thrombosis and Haemostasis.

[21]  J. Soulier,et al.  Différents états moléculaires du facteur II (prothrombine). Leur étude à l’aide de la staphylocoagulase et d’anticorps anti-facteur II , 1968, Thrombosis and Haemostasis.

[22]  J. Scheidegger Une micro-méthode de l’immuno-électrophorèse , 1955 .